ChiYoungOkMD

PubMed

• Childhood and Adolescent Relapsed/Refractory Aggressive B-Cell Lymphomas With t(8;14) and BCL2 Expression, Burkitt Lymphoma Versus Diffuse Large B-Cell Lymphoma: A Dia...
  Fouad El Dana, Sofia Alexandra Garces Narvaez, Nader K El-Mallawany, Jennifer E Agrusa, ZoAnn E Dreyer, Andrea N Marcogliese, Mohamed Tarek Elghetany, Jyotinder N Puni...> ;Pediatric and Developmental Pathology. 2024 Mar 11
• TP53 mutation is frequent in mantle cell lymphoma with EZH2 expression and have dismal outcome when both are present.
  Do Hwan Kim, Saima Siddiqui, Preetesh Jain, Michael Wang, Beenu Thakral, Shaoying Li, Roberto Miranda, Francisco Vega, L Jeffrey Medeiros, Chi Young Ok> ;Human Pathology. 2024 Mar 7
• The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance.
  Mario L Marques-Piubelli, Kirill A Lyapichev, Aakash Fnu, Beatriz Adrada, John Stewart, Kelly K Hunt, Mark W Clemens, Swaminathan Iyer, Yun Wu, Siba El Hussein, Jie Xu...> ;The American Journal of Surgical Pathology. 2024 Mar 4
• Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis.
  Medeiros, L., Nwogbo, O., Fang, H., Wang, W., Xu, J., Miranda, R., Bose, P., Ok, C., Jorgensen, J., Wang, S.> ;American Journal of Clinical Pathology. 2024 Feb 19
• Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
  Wei, Q., Nwogbo, O., You, M., Medeiros, L., Quesada, A., Hu, S., Li, S., Toruner, G., Loghavi, S., Ok, C., Jain, P., Thakral, B., Kim, D., Iyer, S., Tang, G.> ;Human Pathology. 2024 Feb 1
• 1 citations
  Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma.
  Preetesh Jain, Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly Hill, Chi Young Ok, Ahmed Fetooh, Rashmi Kanagal-Shamanna, Francisco Vega, Alexander Bagaev, Nathan ...> ;Blood Cancer Journal. 2023 Oct 12
• 3 citations
  Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection.
  Sa A Wang, Jeffrey L Jorgensen, Shimin Hu, Fuli Jia, Shaoying Li, Sanam Loghavi, Chi Young Ok, Beenu Thakral, Jie Xu, L Jeffrey Medeiros, Wei Wang> ;Cytometry. Part B, Clinical Cytometry. 2023 Sep 1
• Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma.
  Holly A Hill, Preetesh Jain, Chi Young Ok, Koji Sasaki, Han Chen, Michael L Wang, Ken Chen> ;Cancer Research Communications. 2023 Aug 1
• From the archives of MD Anderson Cancer Center: Sporadic Burkitt lymphoma with a complex karyotype and SOX11 expression.
  Saima Haleem Siddiqui, Beenu Thakral, Fnu Aakash, Chi Young Ok, Zhenya Tang, L Jeffrey Medeiros> ;Annals of Diagnostic Pathology. 2023 Oct 1
• 1 citations
  Blastoid and Pleomorphic Mantle Cell Lymphoma Demonstrate Distinct Clinicopathologic and Genetic Features.
  Mahsa Khanlari, Huan Mo, Do Hwan Kim, Ali Sakhdari, Ken H Young, Preetesh Jain, Michael Wang, Shaoying Li, Rashmi Kanagal-Shamanna, Roberto N Miranda, Francisco Vega, ...> ;The American Journal of Surgical Pathology. 2023 Aug 1
• 1 citations
  Utility of p53 immunohistochemistry as a surrogate for sequencing in myeloid neoplasms: A tale of caution.
  Karen A Nahmod, Koji Sasaki, Chi Young Ok, Sanam Loghavi> ;American Journal of Hematology. 2024 Feb 1
• 2 citations
  DDX41 mutations in patients with non-myeloid hematologic neoplasms.
  Fatima Zahra Jelloul, Mark J Routbort, Courtney D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Beenu Thakral, Zhuang Zuo, C Cameron Yin, Sanam Loghavi, Chi ...> ;American Journal of Hematology. 2023 Aug 1
• 4 citations
  CD30 expression is frequently decreased in relapsed classic Hodgkin lymphoma after anti-CD30 CAR T-cell therapy.
  Mario L Marques-Piubelli, Do Hwan Kim, L Jeffrey Medeiros, Wei Lu, Khaja Khan, Lorena Isabel Gomez-Bolanos, Saxon Rodriguez, Edwin R Parra, Chi Young Ok, Akanksha Arad...> ;Histopathology. 2023 Jul 1
• 1 citations
  ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
  Wen Shuai, Zhuang Zuo, Nianyi Li, Sofia Garces, Fatima Zahra Jelloul, Chi Young Ok, Shaoying Li, Jie Xu, M James You, Wei Wang, Catherine Rehder, Elias J Jabbour, Keyu...> ;Cancer. 2023 Mar 15
• Concurrent Mutations inandin Myeloid Neoplasms.
  Zhuang Zuo, L Jeffrey Medeiros, Sofia Garces, Mark J Routbort, Chi Young Ok, Sanam Loghavi, Rashmi Kanagal-Shamanna, Fatima Zahra Jelloul, Guillermo Garcia-Manero, Kel...> ;Biology. 2022 Dec 21
• 4 citations
  High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.
  Shaoying Li, Jie Xu, Pei Lin, Chi Young Ok, Guilin Tang, Timothy J McDonnell, M James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros, Qiu, L.> ;Leukemia. 2023 Feb 1
• Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations.
  Mehrnoosh Tashakori, Joseph D Khoury, Mark J Routbort, Keyur P Patel, Sa A Wang, Chi Young Ok, Siba El-Hussein, Rashmi Kanagal-Shamanna, Rajyalakshmi Luthra, Shimin Hu...> ;Modern Pathology. 2022 Nov 1
• 7 citations
  Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic synd...
  Ali Sakhdari, Caleb Class, Guillermo Montalban-Bravo, Koji Sasaki, Carlos E Bueso-Ramos, Keyur P Patel, Mark J Routbort, Sanam Loghavi, Chi Young Ok, Andres Quesada, J...> ;Modern Pathology. 2022 Sep 1
• 1 citations
  Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia.
  Fatima Zahra Jelloul, Richard Yang, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Y Ok, Sanam Loghavi, Mark J Routbort, Zhuang Zuo, C Cameron Yin, Kristen Floyd, Roland L...> ;Leukemia Research. 2022 May 1
• 16 citations
  Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
  Michael L Wang, Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta Nastoupil, Luis Fayad, Chi Young Ok, Rashmi Kanagal-Shamanna, Holly A Hill, Yixin Yao, Fredrick B Ha...> ;The Lancet. Oncology. 2022 Mar 1
• 1 citations
  Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
  Fatima Zahra Jelloul, Richard K Yang, Peng Wang, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Y Ok, Sanam Loghavi, Mark J Routbort, Zhuang Zuo, Cheng Cameron Yin, Kriste...> ;American Journal of Hematology. 2022 Mar 1
• 8 citations
  Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
  Siba El Hussein, Courtney D DiNardo, Koichi Takahashi, Joseph D Khoury, Hong Fang, Ken Furudate, Kirill A Lyapichev, Sofia Garces, Rashmi Kanagal-Shamanna, Chi Young O...> ;Bone Marrow Transplantation. 2022 Mar 1
• 25 citations
  Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma
  Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Holly Hill, Chi Young Ok, Rashmi Kanagal-Shamanna, Fredrick B. Hagemeister, Nathan Fowler, Luis Fayad, Yixin Yao, Yang Liu, ...> ;Journal of Clinical Oncology. 2021 Nov 19
• 2 citations
  Mantle Cell Lymphoma with Chronic Lymphocytic Leukemia-Like Features: A Diagnostic Mimic and Pitfall.
  Jie Xu, Guilin Tang, Sa A. Wang, Pei Lin, Chi Young Ok, Sophia Garces, C. Cameron Yin, Mahsa Khanlari, Francisco Vega, L. Jeffrey Medeiros, Shaoying Li> ;Human Pathology. 2021 Nov 9
• 2 citations
  Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases.
  Mehrnoosh Tashakori, Do Hwan Kim, Rashmi Kanagal-Shamanna, Francisco Vega, Roberto N. Miranda, Preetesh Jain, Michael Wang, L. Jeffrey Medeiros, Chi Young Ok> ;Human Pathology. 2021 Oct 13
• Join now to see all

Journal Articles

• High-Grade B-cell Lymphomas with TdT Expression: A Diagnostic and Classification Dilemma  
  Chi Young Ok, L Jeffrey Medeiros, Sergej Konoplev, Nitin Jain, Elias Jabbour, Guilin Tang, Nature

Abstracts/Posters

• Frontline Treatment with Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX Is Extremely Potent and Safe in Patients (age _ 65 years) with Mantle C...
  Chi Young Ok, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of Factors Predictive of Risk of Transformation and Time to Transformation in Patients (pts) with Mantle Cell Lymphoma _ Cohort Study of 369 Patients
  Chi Young Ok, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Frontline Treatment with Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hypercvad/MTX Is Extremely Potent and Safe in Patients (age _ 65 years) with Mantle C...
  Chi Young Ok, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Clinical and Genomic Characteristics in De Novo Blastoid/Pleomorphic (dnMCL) and Transformed Blastoid/Pleomorphic (t-MCL) Mantle Cell Lymphoma (MCL) in the Ibrutinib E... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Clinical, Immunophenotypic and Genomic Findings  of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow P... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018